Argus Research Maintains Buy on Eli Lilly, Raises Price Target to $1550

Benzinga · 22h ago
Argus Research analyst Jasper Hellweg maintains Eli Lilly (NYSE:LLY) with a Buy and raises the price target from $1300 to $1550.